These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9347205

  • 1. Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women.
    Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.
    Contraception; 1997 Sep; 56(3):153-5. PubMed ID: 9347205
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
    Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.
    Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
    [Abstract] [Full Text] [Related]

  • 3. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 4. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
    Naessen T, Olsson SE, Gudmundson J.
    Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
    [Abstract] [Full Text] [Related]

  • 5. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
    Virutamasen P, Wangsuphachart S, Reinprayoon D, Kriengsinyot R, Leepipatpaiboon S, Gua C.
    Asia Oceania J Obstet Gynaecol; 1994 Sep; 20(3):269-74. PubMed ID: 7811192
    [Abstract] [Full Text] [Related]

  • 6. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 7. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
    Paiva LC, Pinto-Neto AM, Faundes A.
    Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
    Moore LL, Valuck R, McDougall C, Fink W.
    Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
    [Abstract] [Full Text] [Related]

  • 9. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B, Ellis S, Murby B, Randall S, Kirkman R.
    Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
    [Abstract] [Full Text] [Related]

  • 10. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
    Anwar M, Soejono SK, Maruo T, Abdullah N.
    Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
    [Abstract] [Full Text] [Related]

  • 11. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR.
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M, Koetsawang S, Patrasupapong N, Dinchuen P, d'Arcangues C, Piaggio G, Pinol A.
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [Abstract] [Full Text] [Related]

  • 13. Long-term depot-medroxyprogesterone acetate and bone mineral density.
    Tang OS, Tang G, Yip P, Li B, Fan S.
    Contraception; 1999 Jan; 59(1):25-9. PubMed ID: 10342083
    [Abstract] [Full Text] [Related]

  • 14. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L.
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [Abstract] [Full Text] [Related]

  • 15. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 16. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR.
    BMJ; 1991 Jul 06; 303(6793):13-6. PubMed ID: 1830502
    [Abstract] [Full Text] [Related]

  • 17. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
    Wanichsetakul P, Kamudhamas A, Watanaruangkovit P, Siripakarn Y, Visutakul P.
    Contraception; 2002 Jun 06; 65(6):407-10. PubMed ID: 12127638
    [Abstract] [Full Text] [Related]

  • 18. Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.
    Di X, Li Y, Zhang C, Jiang J, Gu S.
    Contraception; 1999 Sep 06; 60(3):161-6. PubMed ID: 10640160
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women.
    Tharnprisarn W, Taneepanichskul S.
    Contraception; 2002 Aug 06; 66(2):101-3. PubMed ID: 12204782
    [Abstract] [Full Text] [Related]

  • 20. New contraceptives in the 1990s.
    O'Connell BJ.
    Curr Opin Pediatr; 1995 Aug 06; 7(4):371-5. PubMed ID: 7581638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.